Evaluation of a Toothpaste Containing Cetylpyridinium Chloride and Cymenol—A Randomized Clinical Trial
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Ethical Aspects
2.3. Study Population
2.3.1. Inclusion Criteria
- Over 18 years of age;
- Systemically healthy, defined according to the criteria of the American Society of Anesthesiologists (ASA) [16], as ASA type I or II (see also exclusion criteria);
- Presence of at least three evaluable teeth in each quadrant;
- Absence of probing depths (PD) ≥ 5 mm;
- No fixed orthodontic treatments or removable prostheses;
- Brushed their teeth regularly (at least twice a day).
2.3.2. Exclusion Criteria
- Untreated or uncontrolled periodontitis;
- Regular users of mouthwashes during the month prior to the screening;
- Antibiotic intake within the previous month;
- Pregnant women;
- Any chronic disease or medication that may influence gingival inflammation;
- Conditions requiring antibiotic coverage.
2.4. Study Visits and Intervention
2.4.1. Screening Visit
2.4.2. Baseline Visit
2.4.3. Week 3 and Week 6 Visits
2.5. Randomization and Blinding
2.6. Primary Outcome-Safety and Tolerability
2.7. Secondary Outcomes
2.7.1. Compliance
2.7.2. Patient Reported Outcome Measures (PROMs)
2.7.3. Clinical Outcome Variables
- Bleeding on probing (BOP) [24] by dichotomous assessment of bleeding after gentle probing.
2.8. Data Analysis
2.8.1. Sample Size Calculation
2.8.2. Statistical Analysis
3. Results
3.1. Demographic Data
3.2. Primary Outcome-Safety and Tolerability
3.3. Patient Compliance and PROMs
3.4. Clinical Outcomes Variables
3.4.1. Plaque Index (PlI)
3.4.2. Bleeding on Marginal Probing Index (BOMP)
3.4.3. Bleeding on Probing (BOP)
3.4.4. Gründemann Modification of the Stain Index (GMSI)
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Loe, H.; Theilade, E.; Jensen, S.B. Experimental Gingivitis in Man. J. Periodontol. 1965, 36, 177–187. [Google Scholar] [CrossRef] [PubMed]
- Timmerman, M.F.; van der Weijden, G.A. Risk Factors for Periodontitis. Int. J. Dent. Hyg. 2006, 4, 2–7. [Google Scholar] [CrossRef]
- Linden, G.J.; Lyons, A.; Scannapieco, F.A. Periodontal Systemic Associations: Review of the Evidence. J. Clin. Periodontol. 2013, 40 (Suppl. S14), S8–S19. [Google Scholar] [CrossRef] [PubMed]
- Addy, M.; Dummer, P.M.H.; Griffiths, G.; Hicks, R.; Kingdon, A.; Shaw, W.C. Prevalence of Plaque, Gingivitis and Caries in 11–12-Year-Old Children in South Wales. Community Dent. Oral Epidemiol. 1986, 14, 115–118. [Google Scholar] [CrossRef] [PubMed]
- Van Der Weijden, G.A.; Hioe, K.P.K. A Systematic Review of the Effectiveness of Self-Performed Mechanical Plaque Removal in Adults with Gingivitis Using a Manual Toothbrush. J. Clin. Periodontol. 2005, 32, 214–228. [Google Scholar] [CrossRef] [PubMed]
- Serrano, J.; Escribano, M.; Roldan, S.; Martin, C.; Herrera, D. Efficacy of Adjunctive Anti-Plaque Chemical Agents in Managing Gingivitis: A Systematic Review and Meta-Analysis. J. Clin. Periodontol. 2015, 42 (Suppl. S16), S106–S138. [Google Scholar] [CrossRef]
- Figuero, E.; Roldan, S.; Serrano, J.; Escribano, M.; Martin, C.; Preshaw, P.M. Efficacy of Adjunctive Therapies in Patients with Gingival Inflammation: A Systematic Review and Meta-Analysis. J. Clin. Periodontol. 2020, 47 (Suppl. S22), 125–143. [Google Scholar] [CrossRef] [PubMed]
- Flotra, L.; Gjermo, P.; Rolla, G.; Waerhaug, J. Side Effects of Chlorhexidine Mouth Washes. Scand. J. Dent. Res. 1971, 79, 119–125. [Google Scholar] [CrossRef]
- Mao, X.; Auer, D.L.; Buchalla, W.; Hiller, K.A.; Maisch, T.; Hellwig, E.; Al-Ahmad, A.; Cieplik, F. Cetylpyridinium Chloride: Mechanism of Action, Antimicrobial Efficacy in Biofilms, and Potential Risks of Resistance. Antimicrob. Agents Chemother. 2020, 64, e00576-20. [Google Scholar] [CrossRef]
- Council on Dental Therapeutics. Guidelines for Acceptance of Chemotherapeutic Products for the Control of Supragingival Dental Plaque and Gingivitis. J. Am. Dent. Assoc. 1986, 112, 529–532. [Google Scholar] [CrossRef]
- Haps, S.; Slot, D.E.; Berchier, C.E.; Van der Weijden, G.A. The Effect of Cetylpyridinium Chloride-Containing Mouth Rinses as Adjuncts to Toothbrushing on Plaque and Parameters of Gingival Inflammation: A Systematic Review. Int. J. Dent. Hyg. 2008, 6, 290–303. [Google Scholar] [CrossRef]
- Robert, P.A.; Douglas, C.W.I. Novel Anti-Microbial Therapies for Dental Plaque-Related Diseases. Int. J. Antimicrob. Agents 2009, 33, 8–13. [Google Scholar]
- Kakar, A.; Newby, E.E.; Ghosh, S.; Butler, A.; Bosma, M.L. A Randomised Clinical Trial to Assess Maintenance of Gingival Health by a Novel Gel to Foam Dentifrice Containing 0.1%W/W O-Cymen-5-Ol, 0.6%W/W Zinc Chloride. Int. Dent. J. 2011, 61, 21–27. [Google Scholar] [CrossRef] [PubMed]
- Aguilera, F.R.; Viñas, M.; Sierra, J.M.; Vinuesa, T.; Fernandez de Henestrosa, A.R.; Furmanczyk, M.; Trullàs, C.; Jourdan, E.; López-López, J.; Jorba, M. Substantivity of Mouth-Rinse Formulations Containing Cetylpyridinium Chloride and O-Cymen-5-Ol: A Randomized-Crossover Trial. BMC Oral Health 2022, 22, 646. [Google Scholar] [CrossRef] [PubMed]
- Chapple, I.L.C.; Mealey, B.L.; Van Dyke, T.E.; Bartold, P.M.; Dommisch, H.; Eickholz, P.; Geisinger, M.L.; Genco, R.J.; Glogauer, M.; Goldstein, M.; et al. Periodontal Health and Gingival Diseases and Conditions on an Intact and a Reduced Periodontium: Consensus Report of Workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol. 2018, 45 (Suppl. S20), S68–S77. [Google Scholar] [CrossRef]
- Doyle, D.J.; Goyal, A.; Bansal, P.; Garmon, E.H. American Society of Anesthesiologists Classification; StatPearls Publishing: Tampa/St. Petersburg, FL, USA, 2021. [Google Scholar]
- Van der Weijden, G.A.; Timmerman, M.F.; Nijboer, A.; Reijerse, E.; Van der Velden, U. Comparison of Different Approaches to Assess Bleeding on Probing as Indicators of Gingivitis. J. Clin. Periodontol. 1994, 21, 589–594. [Google Scholar] [CrossRef] [PubMed]
- Turesky, S.; Gilmore, N.D.; Glickman, L. Reduced Formation by Chloromethyl Analogue of Vitamin C. J. Periodontol. 1970, 41, 41–43. [Google Scholar] [CrossRef]
- Fleiss, J.L.; Chilton, N.W. The Measurement of Interexaminer Agreement on Periodontal Disease. J. Periodontal Res. 1983, 18, 601–606. [Google Scholar] [CrossRef]
- Gründemann, L.J.; Timmerman, M.F.; IJzerman, Y.; Van der Weijden, U.; Van der Weijden, G.A. Stain, Plaque and Gingivitis Reduction by Combining Chlorhexidine and Peroxyborate. J. Clin. Periodontol. 2000, 27, 9–15. [Google Scholar] [CrossRef]
- Koertge, T.E.; Gunsolley, J.C.; Domke, T.W.; Nelson, B.J. Comparison of Two Dentifrices in the Control of Chlorhexidine-Induced Stain. J. Clin. Dent. 1993, 4, 1–5. [Google Scholar]
- Quigley, G.A.; Hein, J.W. Comparative Cleansing Efficiency of Manual and Power Brushing. J. Am. Dent. Assoc. 1962, 65, 26–29. [Google Scholar] [CrossRef] [PubMed]
- Lie, M.A.; Timmerman, M.F.; Van der Velden, U.; Van der Weijden, G.A. Evaluation of 2 Methods to Assess Gingival Bleeding in Smokers and Non-Smokers in Natural and Experimental Gingivitis. J. Clin. Periodontol. 1998, 25, 695–700. [Google Scholar] [CrossRef] [PubMed]
- Ainamo, J.; Bay, I. Problems and Proposals for Recording Gingivitis and Plaque. Int. Dent. J. 1975, 25, 229–235. [Google Scholar] [PubMed]
- Domenech, J.M.; Granero, R. Macro !NSize for PASW Statistics. Sample Size and Power: Comparisons and Estimations for Independent Proportions, Means, Correlations, Risks and Rates [Computer Program]; V2010.06.30; Universitat Autònoma de Barcelona: Bellaterra, Spain, 2010; Available online: http://www.metodo.uab.cat/macros.htm (accessed on 30 June 2010).
- Lin, G.H.; Voss, K.A.; Davidson, T.J. Acute Inhalation Toxicity of Cetylpyridinium Chloride. Food Chem. Toxicol. 1991, 29, 851–854. [Google Scholar] [CrossRef] [PubMed]
- Food and Drug Administration & Department of Health and Human Services. Oral Health Care Drug Products for over-the-Counter Human Use; Anti-Gingivitis/Anti-Plaque Drug Products; Establishment of a Monograph; Proposed Rules. Fed. Regist. 2003, 68, 32232–32287. [Google Scholar]
- Costa, X.; Laguna, E.; Herrera, D.; Serrano, J.; Alonso, B.; Sanz, M. Efficacy of a New Mouth Rinse Formulation Based on 0.07% Cetylpyridinium Chloride in the Control of Plaque and Gingivitis: A 6-Month Randomized Clinical Trial. J. Clin. Periodontol. 2013, 40, 1007–1015. [Google Scholar] [CrossRef]
- Leung, K.P.; Abercrombie, J.J.; Campbell, T.M.; Gilmore, K.D.; Bell, C.A.; Faraj, J.A.; DeLuca, P.P. Antimicrobial Peptides for Plaque Control. Adv. Dent. Res. 2009, 21, 57–62. [Google Scholar] [CrossRef]
- Pizzey, R.L.; Marquis, R.E.; Bradshaw, D.J. Antimicrobial Effects of O-Cymen-5-Ol and Zinc, Alone & in Combination in Simple Solutions and Toothpaste Formulations. Int. Dent. J. 2011, 61 (Suppl. S3), 33–40. [Google Scholar]
- Herrera, D.; Escudero, N.; Pérez, L.; Otheo, M.; Cañete-Sánchez, E.; Pérez, T.; Alonso, B.; Serrano, J.; Palma, J.C.; Sanz, M.; et al. Clinical and Microbiological Effects of the Use of a Cetylpyridinium Chloride Dentifrice and Mouth Rinse in Orthodontic Patients: A 3-Month Randomized Clinical Trial. Eur. J. Orthod. 2018, 40, 465–474. [Google Scholar] [CrossRef]
- Mankodi, S.; Bauroth, K.; Witt, J.J.; Bsoul, S.; He, T.; Gibb, R.; Dunavent, J.; Hamilton, A. A 6-Month Clinical Trial to Study the Effects of a Cetylpyridinium Chloride Mouthrinse on Gingivitis and Plaque. Am. J. Dent. 2005, 18, 9a–14a. [Google Scholar]
- Stookey, G.K.; Beiswanger, B.; Mau, M.; Isaacs, R.L.; Witt, J.J.; Gibb, R. A 6-Month Clinical Study Assessing the Safety and Efficacy of Two Cetylpyridinium Chloride Mouthrinses. Am. J. Dent. 2005, 18, 24A–28A. [Google Scholar] [PubMed]
- Gunsolley, J.C. A Meta-Analysis of Six-Month Studies of Antiplaque and Antigingivitis Agents. J. Am. Dent. Assoc. 2006, 137, 1649–1657. [Google Scholar] [CrossRef] [PubMed]
- Stoeken, J.E.; Paraskevas, S.; van der Weijden, G.A. The Long-Term Effect of a Mouthrinse Containing Essential Oils on Dental Plaque and Gingivitis: A Systematic Review. J. Periodontol. 2007, 78, 1218–1228. [Google Scholar] [CrossRef] [PubMed]
- Bollain, J.; Pulcini, A.; Sanz-Sánchez, I.; Figuero, E.; Alonso, B.; Sanz, M.; Herrera, D. Efficacy of a 0.03% Chlorhexidine and 0.05% Cetylpyridinium Chloride Mouth Rinse in Reducing Inflammation around the Teeth and Implants: A Randomized Clinical Trial. Clin. Oral Investig. 2021, 25, 1729–1741. [Google Scholar] [CrossRef]
All | Test Group | Control Group | p | ||
---|---|---|---|---|---|
n | 55 | 29 | 26 | ||
Age | Mean (SD) | 41.13 (0.17) | 39.24 (17.77) | 43.23 (18.01) | Mann–Whitney |
Min–Max | 21–74 | 21–72 | 21–74 | 0.438 | |
Gender | Male [n (%)] | 23 (41.8) | 11 (37.9) | 12 (46.2) | Chi-square |
Female [n (%)] | 32 (58.2) | 18 (62.1) | 14 (53.8) | 0.537 | |
Smoking | No [n (%)] | 50 (90.9) | 26 (89.7) | 24 (92.3) | Fisher exact |
Yes [n (%)] | 5 (9.1) | 3 (10.3) | 2 (7.7) | 1.000 | |
Systemic conditions | No [n (%)] | 47 (85.5) | 23 (79.3) | 24 (92.3) | Fisher exact |
Yes [n (%)] | 8 (14.5) | 6 (20.7) | 2 (7.7) | 0.257 | |
Chronic medications | No [n (%)] | 35 (63.6) | 18 (62.1) | 17 (65.4) | Chi-square |
Yes [n (%)] | 20 (36.4) | 11 (37.9) | 9 (34.6) | 0.799 | |
Allergies | No [n (%)] | 50 (90.9) | 26 (89.7) | 24 (92.3) | Fisher exact |
Yes [n (%)] | 5 (9.1) | 3 (10.3) | 2 (7.7) | 1.000 | |
Stress | No [n (%)] | 35 (63.6) | 20 (69.0) | 15 (57.7) | Chi-square |
Yes [n (%)] | 20 (36.4) | 9 (31.0) | 11 (42.3) | 0.386 |
Test Group | Control Group | Mean Difference | 95% CI | p | ||
---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | Lower Bound | Upper Bound | |||
n | 28 | 22 | ||||
3 weeks | 59.67 (33.35) | 61.12 (38.70) | −1.456 | −21.96 | 19.04 | 0.887 |
6 weeks | 61.67 (35.51) | 41.48 (38.20) | 20.192 | −0.83 | 41.22 | 0.059 |
Total | 122.10 (41.45) | 107.19 (51.10) | 14.915 | −11.39 | 41.22 | 0.260 |
Test Group | Control Group | p | |||||
---|---|---|---|---|---|---|---|
n | Mean (SD) | Median (IQR) | n | Mean (SD) | Median (IQR) | ||
Consistency | 30 | 3.66 (0.37) | 3.75 (0.50) | 30 | 3.70 (0.38) | 4.00 (0.50) | 0.683 |
Aroma | 30 | 3.50 (0.45) | 3.50 (1.00) | 30 | 3.56 (0.44) | 3.50 (1.00) | 0.581 |
Taste | 30 | 3.45 (0.57) | 3.50 (1.00) | 30 | 3.60 (0.48) | 4.00 (1.00) | 0.324 |
Amount of foam | 30 | 3.50 (0.55) | 3.50 (1.00) | 30 | 3.51 (0.59) | 3.75 (1.00) | 0.794 |
Freshness | 30 | 3.05 (0.72) | 3.00 (0.50) | 30 | 3.26 (0.61) | 3.25 (1.00) | 0.278 |
Cleanness feeling | 30 | 3.26 (0.66) | 3.50 (0.63) | 30 | 3.38 (0.55) | 3.25 (1.00) | 0.672 |
Healthier teeth feeling | 30 | 3.03 (0.66) | 3.00 (0.50) | 30 | 3.28 (0.55) | 3.25 (0.63) | 0.119 |
Fresh mouth | 30 | 3.18 (0.66) | 3.00 (0.63) | 30 | 3.36 (0.61) | 3.50 (1.00) | 0.264 |
Fresh breath | 30 | 3.08 (0.67) | 3.00 (0.63) | 30 | 3.25 (0.65) | 3.25 (1.00) | 0.278 |
Less swollen gums | 30 | 3.00 (0.57) | 3.00 (1.00) | 30 | 3.11 (0.72) | 3.00 (1.13) | 0.339 |
Reduced gum bleeding | 30 | 3.21 (0.61) | 3.00 (0.63) | 29 | 3.15 (0.75) | 3.00 (1.00) | 0.900 |
Lasting reduction of bleeding and swelling | 30 | 3.01 (0.71) | 3.00 (1.00) | 28 | 3.12 (0.66) | 3.00 (1.38) | 0.671 |
Healthy mouth feeling | 30 | 3.21 (0.58) | 3.25 (0.50) | 30 | 3.40 (0.59) | 3.50 (1.00) | 0.217 |
Gentle on gums | 30 | 3.61 (0.42) | 3.50 (0.50) | 30 | 3.60 (0.44) | 3.75 (1.00) | 0.905 |
Sensitive gum care | 30 | 3.46 (0.57) | 3.50 (1.00) | 30 | 3.43 (0.52) | 3.50 (1.00) | 0.664 |
Removes dental plaque | 30 | 2.98 (0.63) | 3.00 (0.63) | 29 | 3.34 (0.58) | 3.00 (1.00) | 0.017 |
Stronger teeth feeling | 30 | 3.03 (0.49) | 3.00 (0.13) | 30 | 3.15 (0.60) | 3.00 (0.50) | 0.321 |
Stronger gum feeling | 30 | 3.18 (0.56) | 3.00 (0.50) | 29 | 3.10 (0.71) | 3.00 (0.50) | 0.911 |
Gum relief feeling | 30 | 3.18 (0.51) | 3.00 (0.50) | 30 | 3.30 (0.61) | 3.00 (1.00) | 0.437 |
Overall rating | 30 | 3.05 (0.59) | 3.00 (0.50) | 30 | 3.33 (0.46) | 3.00 (1.00) | 0.077 |
Buy the product | 30 | 3.05 (0.68) | 3.00 (0.63) | 30 | 3.21 (0.50) | 3.00 (0.50) | 0.371 |
Recommend the product | 30 | 3.15 (0.61) | 3.00 (0.63) | 30 | 3.20 (0.50) | 3.00 (0.50) | 0.760 |
Product evaluation | 19 | 7.65 (1.10) | 8.00 (1.00) | 18 | 8.00 (1.28) | 8.00 (2.00) | 0.558 |
Test Group | Control Group | Mean Difference | 95% CI Bounds | p | ||
---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | Lower | Upper | |||
n | 29 | 26 | ||||
All sites | ||||||
Baseline | 2.72 (0.40) * | 2.78 (0.36) | −0.069 | −0.27 | 0.14 | 0.514 |
3 weeks | 2.43 (0.36) | 2.65 (0.33) | −0.215 | −0.40 | −0.02 | 0.028 |
6 weeks | 2.38 (0.43) ** | 2.64 (0.28) | −0.265 | −0.46 | −0.06 | 0.011 |
Change BL-3w | 0.28 (0.37) | 0.13 (0.39) | 0.146 | −0.06 | 0.35 | 0.167 |
Change BL-6w | 0.33 (0.44) | 0.14 (0.40) | 0.195 | −0.03 | 0.42 | 0.095 |
Buccal | ||||||
Baseline | 2.70 (0.52) * | 2.68 (0.45) | 0.013 | −0.25 | 0.28 | 0.921 |
3 weeks | 2.44 (0.47) | 2.52 (0.43) | −0.078 | −0.32 | 0.16 | 0.530 |
6 weeks | 2.39 (0.49) ** | 2.53 (0.38) | −0.142 | −0.38 | 0.09 | 0.243 |
Change BL-3w | 0.25 (0.43) | 0.16 (0.50) | 0.091 | −0.16 | 0.34 | 0.477 |
Change BL-6w | 0.30 (0.55) | 0.15 (0.46) | 0.154 | −0.12 | 0.43 | 0.270 |
Lingual | ||||||
Baseline | 2.74 (0.49) * | 2.89 (0.41) | −0.151 | −0.39 | 0.09 | 0.225 |
3 weeks | 2.43 (0.40) | 2.78 (0.36) | −0.353 | −0.56 | −0.14 | 0.001 |
6 weeks | 2.37 (0.50) ** | 2.76 (0.32) | −0.389 | −0.62 | −0.15 | 0.002 |
Change BL-3w | 0.30 (0.43) | 0.10 (0.38) | 0.201 | −0.02 | 0.42 | 0.076 |
Change BL-6w | 0.36 (0.46) | 0.12 (0.41) | 0.237 | −0.00 | 0.47 | 0.051 |
Proximal | ||||||
Baseline | 2.86 (0.40) * | 2.93 (0.39) | −0.063 | −0.28 | 0.15 | 0.564 |
3 weeks | 2.58 (0.38) | 2.80 (0.34) | −0.222 | −0.42 | −0.02 | 0.030 |
6 weeks | 2.51 (0.46) ** | 2.80 (0.26) | −0.284 | −0.49 | −0.07 | 0.008 |
Change BL-3w | 0.28 (0.39) | 0.12 (0.38) | 0.137 | −0.05 | 0.37 | 0.137 |
Change BL-6w | 0.34 (0.45) | 0.12 (0.41) | 0.220 | −0.01 | 0.45 | 0.067 |
Test Group | Control Group | p | |||
---|---|---|---|---|---|
Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | ||
n | 29 | 29 | 26 | 26 | |
All sites | |||||
Baseline | 0.29 (0.17) | 0.25 (0.25) * | 0.31 (0.18) | 0.29 (0.18) * | 0.913 |
3 weeks | 0.18 (0.15) | 0.13 (0.13) | 0.20 (0.16) | 0.19 (0.15) | 0.315 |
6 weeks | 0.14 (0.12) | 0.12 (0.15) ** | 0.21 (0.16) | 0.17 (0.15) ** | 0.085 |
Change BL-3w | 0.11 (0.14) | 0.09 (0.17) | 0.10 (0.13) | 0.07 (0.19) | 0.418 |
Change BL-6w | 0.15 (0.11) | 0.11 (0.19) | 0.10 (0.14) | 0.08 (0.17) | 0.189 |
Buccal | |||||
Baseline | 0.24 (0.19) | 0.19 (0.24) * | 0.24 (0.16) | 0.19 (0.12) * | 0.698 |
3 weeks | 0.14 (0.15) | 0.08 (0.15) | 0.14 (0.11) | 0.11 (0.11) | 0.375 |
6 weeks | 0.10 (0.12) | 0.06 (0.16) ** | 0.13 (0.13) | 0.08 (0.12) ** | 0.174 |
Change BL-3w | 0.10 (0.17) | 0.08 (0.16) | 0.10 (0.13) | 0.10 (0.17) | 0.813 |
Change BL-6w | 0.14 (0.12) | 0.09 (0.19) | 0.11 (0.15) | 0.11 (0.14) | 0.680 |
Lingual | |||||
Baseline | 0.35 (0.18) | 0.31 (0.23) * | 0.38 (0.25) | 0.36 (0.29) * | 0.704 |
3 weeks | 0.22 (0.18) | 0.17 (0.17) | 0.27 (0.23) | 0.20 (0.21) | 0.362 |
6 weeks | 0.19 (0.15) | 0.15 (0.17) ** | 0.28 (0.23) | 0.21 (0.27) | 0.049 |
Change BL-3w | 0.12 (0.17) | 0.13 (0.17) | 0.11 (0.18) | 0.05 (0.25) | 0.292 |
Change BL-6w | 0.16 (0.15) | 0.14 (0.21) | 0.09 (0.16) | 0.08 (0.28) | 0.159 |
Proximal | |||||
Baseline | 0.36 (0.21) | 0.31 (0.33) * | 0.37 (0.27) | 0.29 (0.25) * | 0.906 |
3 weeks | 0.22 (0.22) | 0.14 (0.15) | 0.24 (0.21) | 0.20 (0.21) | 0.197 |
6 weeks | 0.18 (0.18) | 0.12 (0.24) ** | 0.25 (0.22) | 0.21 (0.22) ** | 0.093 |
Change BL-3w | 0.14 (0.20) | 0.12 (0.19) | 0.12 (0.17) | 0.11 (0.26) | 0.433 |
Change BL-6w | 0.18 (0.15) | 0.14 (0.26) | 0.11 (0.17) | 0.11 (0.22) | 0.152 |
Test Group | Control Group | Mean Difference | 95% CI Bounds | p | ||
---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | Lower | Upper | |||
n | 29 | 26 | ||||
All sites | ||||||
Baseline | 0.46 (0.13) * | 0.42 (0.16) * | 0.045 | −0.03 | 0.12 | 0.274 |
3 weeks | 0.29 (0.13) | 0.28 (0.19) | 0.002 | −0.08 | 0.09 | 0.961 |
6 weeks | 0.26 (0.13) ** | 0.30 (0.14) ** | −0.031 | −0.10 | 0.04 | 0.412 |
Change BL-3w | 0.17 (0.14) | 0.13 (0.11) | 0.042 | −0.02 | 0.11 | 0.238 |
Change BL-6w | 0.19 (0.13) | 0.12 (0.10) | 0.075 | 0.00 | 0.14 | 0.031 |
Buccal | ||||||
Baseline | 0.36 (0.16) * | 0.31 (0.18) * | 0.050 | −0.04 | 0.14 | 0.287 |
3 weeks | 0.21 (0.13) | 0.22 (0.15) | −0.007 | −0.08 | 0.07 | 0.857 |
6 weeks | 0.20 (0.12) ** | 0.23 (0.12) ** | −0.037 | −0.10 | 0.03 | 0.290 |
Change BL-3w | 0.15 (0.14) | 0.09 (0.14) | 0.057 | −0.02 | 0.13 | 0.148 |
Change BL-6w | 0.16 (0.12) | 0.07 (0.16) | 0.087 | 0.00 | 0.16 | 0.028 |
Lingual | ||||||
Baseline | 0.56 (0.15) * | 0.52 (0.17) * | 0.039 | −0.05 | 0.12 | 0.395 |
3 weeks | 0.36 (0.18) | 0.35 (0.24) | 0.013 | −0.10 | 0.13 | 0.819 |
6 weeks | 0.32 (0.17) ** | 0.35 (0.20) ** | −0.023 | −0.12 | 0.07 | 0.649 |
Change BL-3w | 0.19 (0.17) | 0.17 (0.13) | 0.025 | −0.06 | 0.11 | 0.555 |
Change BL-6w | 0.22 (0.19) | 0.16 (0.11) | 0.062 | −0.02 | 0.14 | 0.147 |
Proximal | ||||||
Baseline | 0.53 (0.14) * | 0.50 (0.15) * | 0.035 | −0.04 | 0.11 | 0.403 |
3 weeks | 0.33 (0.16) | 0.33 (0.21) | 0.000 | −0.10 | 0.10 | 0.996 |
6 weeks | 0.31 (0.17) ** | 0.35 (0.15) ** | −0.042 | −0.13 | 0.04 | 0.360 |
Change BL-3w | 0.19 (0.17) | 0.16 (0.14) | 0.034 | −0.05 | 0.12 | 0.433 |
Change BL-6w | 0.22 (0.15) | 0.14 (0.12) | 0.076 | −0.00 | 0.15 | 0.051 |
Test Group | Control Group | p | |||
---|---|---|---|---|---|
Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | ||
n | 29 | 29 | 26 | 26 | |
All | |||||
Baseline | 0.38 (0.27) | 0.41 (0.35) | 0.39 (0.26) | 0.40 (0.26) | 0.960 |
3 weeks | 0.38 (0.25) | 0.42 (0.30) | 0.39 (0.26) | 0.40 (0.31) | 0.807 |
6 weeks | 0.39 (0.25) | 0.42 (0.30) | 0.41 (0.28) | 0.40 (0.33) | 0.807 |
Change BL-3w | 0.00 (0.08) | 0.00 (0.01) | −0.00 (0.05) | 0.00 (0.01) | 0.792 |
Change BL-6w | −0.00 (0.09) | 0.00 (0.01) | −0.02 (0.06) | 0.00 (0.03) | 0.892 |
Marginal | |||||
Baseline | 0.36 (0.27) | 0.41 (0.40) | 0.34 (0.27) | 0.33 (0.36) | 0.691 |
3 weeks | 0.34 (0.24) | 0.33 (0.40) | 0.36 (0.30) | 0.33 (0.40) | 0.980 |
6 weeks | 0.35 (0.24) | 0.33 (0.39) | 0.39 (0.32) | 0.36 (0.47) | 0.926 |
Change BL-3w | 0.02 (0.12) | 0.00 (0.01) | −0.01 (0.09) | 0.00 (0.01) | 0.640 |
Change BL-6w | 0.01 (0.12) | 0.00 (0.01) | −0.04 (0.12) | −0.00 (0.08) | 0.057 |
Incisal | |||||
Baseline | 0.40 (0.31) | 0.50 (0.46) | 0.43 (0.27) | 0.45 (0.16) | 0.818 |
3 weeks | 0.42 (0.30) | 0.50 (0.41) | 0.42 (0.26) | 0.49 (0.21) | 0.959 |
6 weeks | 0.43 (0.30) | 0.50 (0.32) | 0.43 (0.27) | 0.48 (0.21) | 0.959 |
Change BL-3w | −0.01 (0.09) | 0.00 (0.00) | 0.00 (0.04) | 0.00 (0.00) | 0.658 |
Change BL-6w | −0.02 (0.10) | 0.00 (0.00) | 0.00 (0.03) | 0.00 (0.00) | 0.917 |
Proximal | |||||
Baseline | 0.63 (0.48) | 0.75 (0.96) | 0.67 (0.38) | 0.75 (0.45) | 0.986 |
3 weeks | 0.63 (0.46) | 0.67 (0.84) | 0.67 (0.39) | 0.74 (0.48) | 0.728 |
6 weeks | 0.64 (0.45) | 0.73 (0.84) | 0.69 (0.41) | 0.74 (0.45) | 0.741 |
Change BL-3w | −0.00 (0.13) | 0.00 (0.01) | 0.00 (0.05) | 0.00 (0.01) | 0.986 |
Change BL-6w | −0.00 (0.13) | 0.00 (0.00) | −0.02 (0.07) | −0.00 (0.06) | 0.075 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vasconcelos, V.; Laciar, F.; Matesanz, P.; Iniesta, M.; Alonso, B.; Roldán, S.; Serrano, J.; Furmanczyk, M.; Bustos, J.; Trullas, C.; et al. Evaluation of a Toothpaste Containing Cetylpyridinium Chloride and Cymenol—A Randomized Clinical Trial. Appl. Sci. 2024, 14, 105. https://doi.org/10.3390/app14010105
Vasconcelos V, Laciar F, Matesanz P, Iniesta M, Alonso B, Roldán S, Serrano J, Furmanczyk M, Bustos J, Trullas C, et al. Evaluation of a Toothpaste Containing Cetylpyridinium Chloride and Cymenol—A Randomized Clinical Trial. Applied Sciences. 2024; 14(1):105. https://doi.org/10.3390/app14010105
Chicago/Turabian StyleVasconcelos, Viviane, Florencia Laciar, Paula Matesanz, Margarita Iniesta, Bettina Alonso, Silvia Roldán, Jorge Serrano, Marta Furmanczyk, Javier Bustos, Carles Trullas, and et al. 2024. "Evaluation of a Toothpaste Containing Cetylpyridinium Chloride and Cymenol—A Randomized Clinical Trial" Applied Sciences 14, no. 1: 105. https://doi.org/10.3390/app14010105
APA StyleVasconcelos, V., Laciar, F., Matesanz, P., Iniesta, M., Alonso, B., Roldán, S., Serrano, J., Furmanczyk, M., Bustos, J., Trullas, C., Jourdan, E., Sanz, M., & Herrera, D. (2024). Evaluation of a Toothpaste Containing Cetylpyridinium Chloride and Cymenol—A Randomized Clinical Trial. Applied Sciences, 14(1), 105. https://doi.org/10.3390/app14010105